Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Heart and Vessels
|
August 16, 2002
Free-floating ball thrombus in the left atrium
Omer Cakir, Nesimi Eren, Ahmet Oruç, et al.
Current Oncology (Toronto, Ont.)
|
September 26, 2025
Impact of Body Composition on Progression-Free Survival in Patients with Metastatic Breast Cancer Treated with Ribociclib
Ahmet Oruç, Mustafa Erol, Özlem Şahin, et al.
Veterinary Sciences
|
May 26, 2026
Investigation of the Effects of Using Natural Fermented Lactic Acid Bacteria as Probiotics on Fattening Performance, Blood Parameters, and Intestinal Microflora in Broiler Chickens Under Heat Stress
Sadık Serkan Aydin, Mehmet Avci, Nurcan Kirar, et al.
European Journal of Clinical Pharmacology
|
February 19, 2025
Prognostic value of IMDC score in non-small cell lung cancer receiving immunotherapy: old dog, new tricks? : IMDC in lung cancer immunotherapy
İsmail Beypınar, Semiha Urvay, Müslih Ürün, et al.
Laryngoscope Investigative Otolaryngology
|
June 25, 2026
Clinical and Social Determinants of Treatment Adherence in Cancer Patients: The Contributory Role of Hearing Loss
Bilgeşah Kılıçtaş, Ahmet Ufuk Kılıçtaş, Rukiye Özçelik Erdem, et al.
American Journal of Cancer Research
|
July 16, 2025
Are they all the same? Different effects of opioid types on survival in metastatic NSCLC receiving nivolumab
Onur Yazdan Balçık, İsmail Beypınar, Semiha Urvay, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals
|
January 24, 2026
Evaluation of Inflammatory Parameters and Ferritin as Prognostic Factors in Non-small Cell Lung Cancer Patients Receiving Nivolumab Immunotherapy
İsmail Beypınar, Onur Yazdan Balçık, Semiha Urvay, et al.
Current Oncology (Toronto, Ont.)
|
December 24, 2025
Real-World Predictors of Survival in CDK4/6 Inhibitor-Treated Metastatic Breast Cancer: The Significance of ER Expression Level and Treatment Naivety
Büşra Bülbül, Bekir Ucun, Can Cangür, et al.
Breast Cancer (Dove Medical Press)
|
March 23, 2026
Endocrine Therapy versus Chemotherapy After CDK4/6 Inhibitor Progression in HR+/HER2- Metastatic Breast Cancer: A Multicenter Real-World Study from Turkey
Can Cangür, Büşra Bülbül, Irem Turgut Yeğen, et al.
Scientific Reports
|
March 27, 2026
The effect of switching from ribociclib to palbociclib due to toxicity in hormone receptor-positive, HER2-negative metastatic breast cancer: a real-world, multicenter, retrospective study
Ahmet Oruç, İlknur Deliktaş Onur, Galip Can Uyar, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Heart and Vessels
|
August 16, 2002
Free-floating ball thrombus in the left atrium
Omer Cakir, Nesimi Eren, Ahmet Oruç, et al.
Current Oncology (Toronto, Ont.)
|
September 26, 2025
Impact of Body Composition on Progression-Free Survival in Patients with Metastatic Breast Cancer Treated with Ribociclib
Ahmet Oruç, Mustafa Erol, Özlem Şahin, et al.
Veterinary Sciences
|
May 26, 2026
Investigation of the Effects of Using Natural Fermented Lactic Acid Bacteria as Probiotics on Fattening Performance, Blood Parameters, and Intestinal Microflora in Broiler Chickens Under Heat Stress
Sadık Serkan Aydin, Mehmet Avci, Nurcan Kirar, et al.
European Journal of Clinical Pharmacology
|
February 19, 2025
Prognostic value of IMDC score in non-small cell lung cancer receiving immunotherapy: old dog, new tricks? : IMDC in lung cancer immunotherapy
İsmail Beypınar, Semiha Urvay, Müslih Ürün, et al.
Laryngoscope Investigative Otolaryngology
|
June 25, 2026
Clinical and Social Determinants of Treatment Adherence in Cancer Patients: The Contributory Role of Hearing Loss
Bilgeşah Kılıçtaş, Ahmet Ufuk Kılıçtaş, Rukiye Özçelik Erdem, et al.
American Journal of Cancer Research
|
July 16, 2025
Are they all the same? Different effects of opioid types on survival in metastatic NSCLC receiving nivolumab
Onur Yazdan Balçık, İsmail Beypınar, Semiha Urvay, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals
|
January 24, 2026
Evaluation of Inflammatory Parameters and Ferritin as Prognostic Factors in Non-small Cell Lung Cancer Patients Receiving Nivolumab Immunotherapy
İsmail Beypınar, Onur Yazdan Balçık, Semiha Urvay, et al.
Current Oncology (Toronto, Ont.)
|
December 24, 2025
Real-World Predictors of Survival in CDK4/6 Inhibitor-Treated Metastatic Breast Cancer: The Significance of ER Expression Level and Treatment Naivety
Büşra Bülbül, Bekir Ucun, Can Cangür, et al.
Breast Cancer (Dove Medical Press)
|
March 23, 2026
Endocrine Therapy versus Chemotherapy After CDK4/6 Inhibitor Progression in HR+/HER2- Metastatic Breast Cancer: A Multicenter Real-World Study from Turkey
Can Cangür, Büşra Bülbül, Irem Turgut Yeğen, et al.
Scientific Reports
|
March 27, 2026
The effect of switching from ribociclib to palbociclib due to toxicity in hormone receptor-positive, HER2-negative metastatic breast cancer: a real-world, multicenter, retrospective study
Ahmet Oruç, İlknur Deliktaş Onur, Galip Can Uyar, et al.
Page
of 2